Therapy News and Research

RSS

UF researchers test stem cell therapy for heart patients

University of Florida doctors on Wednesday (Oct. 3) treated their first patient enrolled in a new study designed to test whether injecting stem cells into the heart helps restore blood flow to the organ by prompting new blood vessels to grow.

4 Oct 2007

Sex after chronic heart failure

Although medication can help extend the lives of men with chronic heart failure, several factors associated with this disease can interfere with a person's ability to engage in and enjoy sexual activities.

4 Oct 2007

Genzyme receives Japanese marketing approval for Elaprase

Genzyme Corp. has announced that it has received approval to market Elaprase (idursulfase) in Japan for the treatment of Hunter syndrome.

4 Oct 2007

Gates Foundation leads the charge against tuberculosis with Northeastern University

Northeastern University announced that Dr. Kim Lewis, Professor of Biology and Director of the Antimicrobial Center, is among the recipients of $280 million in grants the Bill & Melinda Gates Foundation has dedicated to help support the research and speed the development of TB vaccines, diagnostic tests, and treatments.

4 Oct 2007

Even mildly underactive thyroid doubles risk of heart conditions

Individuals with subclinical hypothyroidism - a mildly underactive thyroid only detectable by a blood test - are twice as likely to develop heart failure, compared to those with normal thyroid levels, according to a new study presented on Thursday, Oct. 4, at the 78th Annual Meeting of the American Thyroid Association (ATA) in New York.

4 Oct 2007

When it comes to treatment for heart attacks white men get a better deal

Researchers at Duke University Medical Center (DCRI) in the United States say there is disparity in the treatment men and women receive for heart failure in hospitals.

4 Oct 2007

Promising trial results show biologic therapy ustekinumab significantly improved psoriasis

The first reported findings from an international, Phase 3 study showed that more than two-thirds of patients with moderate to severe plaque psoriasis receiving two doses of ustekinumab (CNTO 1275) achieved at least a 75 percent reduction in psoriasis at week 12, the primary endpoint of the study, as measured by the Psoriasis Area and Severity Index (PASI 75).

4 Oct 2007

Radiofrequency ablation for chronic arthritis-related back pain

Radiofrequency ablation, where heat energy destroys or stuns the nerves of a painful joint, is a developing therapy for chronic arthritis-related back pain.

4 Oct 2007

Cancer trial combines multiple drugs to attack blood vessel formation in patients with kidney cancer

In the first clinical trial of its kind, researchers at the University of Pennsylvania School of Medicine and the Abramson Cancer Center will lead a nationwide test of anti-cancer drug combinations that target blood vessel growth in patients with advanced kidney cancer.

4 Oct 2007

Gene-chip studies provide new leads in treating abnormal lung development in premature newborns

Some 20 to 40 percent of extremely premature infants suffer abnormal lung development leading to bronchopulmonary dysplasia, a chronic lung disease that can cause long-term breathing problems.

4 Oct 2007

FDA tightens potency specifications to ensure thyroid drugs last

The U.S. Food and Drug Administration is tightening the potency specifications for levothyroxine sodium, used to treat underactive thyroid glands and other thyroid conditions, to ensure the drug retains its potency over its entire shelf life.

4 Oct 2007

Large gap between physician and patient understanding of necessity of monthly periods

More than the two thirds of the women in a national survey say that they are interested in suppressing their menstrual periods but many of them aren't sure if it's safe.

4 Oct 2007

Big bucks for cooling therapy trial for children with brain injuries

An investment of $11.5 million is being made into a clinical trial to examine a therapy for children with brain injuries.

3 Oct 2007

Prostate cancer treatment may encourage spread of cancer cells

According to a new study by researchers in the U.S. the popular prostate cancer treatment, androgen deprivation therapy, may in fact encourage the spread of cancer cells throughout the body.

3 Oct 2007

Additional biopsy-scoring data may help determine prostate cancer prognosis

Men with certain scores and patterns based on prostate cancer biopsy were found to be at higher risk of PSA-failure, suggesting that this measurement could help predict the risk of prostate cancer recurrence, according to preliminary research published in the October 3 issue of JAMA.

3 Oct 2007

Ovarian Cancer Biomarker Research Act of 2007 introduced

The Ovarian Cancer Biomarker Research Act of 2007 was introduced in the U.S. House of Representatives on Thursday, Sept. 27 and the Society of Gynecologic Oncologists (SGO), the leader of four organizations integral in drafting this legislation, is issuing a "call to action" for ovarian cancer survivors, their families, and their physicians.

3 Oct 2007

Missouri-Columbia researchers look at mechanisms of cisplatin drug sensitivity

Resistance to chemotherapy treatments can be the worst news a cancer patient ever receives. A pair of researchers at the University of Missouri-Columbia is working steadfastly to learn why some tumors eventually build a tolerance to the common chemotherapy drug cisplatin, in hopes of identifying the particular genes that can be manipulated to make treatment as effective as possible.

3 Oct 2007

Implantable cardioverter defibrillators underused in women, minorities with heart failure

Many Americans hospitalized for heart failure are coming up short when it comes to getting the therapy they need - especially women and minorities, say researchers at Duke University Medical Center.

3 Oct 2007

Doctor involved in HIV infusion therapy scam sentenced to 18 months

A doctor involved in a $7 million HIV infusion therapy scheme to defraud Medicare has been sentenced to 18 months in prison, seven months home confinement, and three years supervised release, Assistant Attorney General Alice S. Fisher of the Criminal Division and U.S. Attorney R. Alexander Acosta of the Southern District of Florida announced today.

3 Oct 2007

Imatinib has ability to cure type of leukemia

In people with chronic myeloid leukemia (CML), the drug Imatinib has been shown to drive cancer into remission, but the disease often returns when treatment is stopped.

3 Oct 2007